Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis.

Ely EW, Laterre PF, Angus DC, Helterbrand JD, Levy H, Dhainaut JF, Vincent JL, Macias WL, Bernard GR, PROWESS Investigators
Crit Care Med. 2003 31 (1): 12-9

PMID: 12544987 · DOI:10.1097/00003246-200301000-00002

MeSH Terms (18)

Adult Aged Analysis of Variance Anti-Infective Agents APACHE Double-Blind Method Female Hemorrhage Humans Logistic Models Male Middle Aged Multivariate Analysis Protein C Recombinant Proteins Risk Factors Sepsis Survival Rate

Connections (1)

This publication is referenced by other Labnodes entities: